On Nov. 28, 2016, Teva Pharmaceuticals (NYSE:TEVA) announced that it had entered into an agreement with Syqe Medical to market and distribute Syqe’s medical cannabis inhaler in Israel for pain management, signifying the first time a medical cannabis product will be marketed by an international pharmaceutical company.